KOPRANNSEKopran Limited· PharmaceuticalsLowNeutral
Announced Fri, 10 Apr · 17:24 IST

Kopran Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

KOPRAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹157.70
prior close
₹154.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-0.6-0.1+0.2-1.3+1.0+0.2-1.7-3.6+2.7+4.3-1.9+16.7+31.0
Up moveDown movePending
AI summary

Surendra Somani, on behalf of the Promoter and Promoter Group of Kopran Limited, has submitted a yearly declaration to BSE and NSE as required under SEBI's Takeover Regulations. The declaration states that the promoters and persons acting in concert have not created any encumbrance (such as pledge, lien, or charge) on the shares of Kopran Limited during the financial year 2025-26. The list of promoters and promoter group entities covered in the declaration includes 4 individual promoters and 15 promoter group entities/individuals. This is a routine annual compliance filing required from all listed companies.

Likely market impact

This is a routine regulatory disclosure with no material impact on shareholders. It simply confirms that promoters did not pledge or otherwise encumber their shares during the year, which is neutral to slightly positive news as it indicates no forced selling risk from pledged shares.